OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
Key Highlights
- ➤Seven-figure multiyear agreement expands OneMedNet’s (ONMD) data licensing revenue
- ➤Customer will commercialize derivative dataset combining molecular and OneMedNet data
- ➤Recurring sublicensing revenue paid on each downstream end-customer license
- ➤Agreement includes option to expand data volume and contract value
- ➤Data sourced directly from more than 2,300 healthcare partner sites
Expert Statements
Aaron Green, President & CEO of OneMedNet
“Sophisticated AI companies in healthcare are not buying one-time data pulls. They want a long-term source of multimodal, regulatory-grade data, direct from the source, at the quality required to build models and commercialize their data products.”
Aaron Green, President & CEO of OneMedNet
“That is this agreement: a seven figure multiyear license, plus a derivative dataset our partner will commercialize, with OneMedNet paid on every downstream license — multiyear licenses, sublicensing on solutions built with our data, and room to expand.”
MINNEAPOLIS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real World Data (RWD), today announced a seven figure multiyear agreement to deliver de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company.
The data will be delivered to the customer through OneMedNet’s iRWD™ Platform. The customer intends to use the data to train AI-enabled clinical and diagnostic models and to create a licensable derivative dataset to sell into its own channel, linking the customer’s molecular datasets with OneMedNet’s first-party imaging and longitudinal clinical journeys. Combined, the derived product is designed to be more valuable and more actionable for life-sciences customer base than either source alone.
Get started
Create a free account to read the full story.